Introduction
In the NOVA sodium and potassium analyser*, ion-selective electrodes measure sodium and potassium by direct potentiometry in separated plasma or serum or in the plasma phase of whole blood and in urine after dilution. Sodium is measured using a glass electrode and potassium using a valinomycin electrode. The sodium, potassium and reference electrodes all have a straight tube design and these are connected to a sampling probe, peristaltic pump and reagent pack via tubing and a pinch valve system. Samples can be aspirated from sample cups, capillary tubes or syringes. The sample volume required is 300 tl for blood, plasma or serum, or 100 ktl for urine.
The NOVA is controlled by a microprocessor which initiates a two point calibration of the electrodes at 2 hourly intervals. A single point calibration with an aqueous standard is automatically carried out with the analysis of each specimen and the test result is displayed 58 seconds after the start of the sample aspiration cycle. The microprocessor also monitors the performance of the system and if a system fault is detected this is identified and a fault status code displayed.
Urine diluent, standards, reference solution and a waste container, are all supplied in a disposable reagent pack within the instrument. The main operating controls consist of two push buttons labelled 'calibrate' and 'analyze', and auxiliary controls are also present. These comprise of a series of push buttons for other functions such as purging the system using a fast pump speed, testing the system display, displaying output from electrodes in millivolts and setting up the instrument for analysis in either 'blood' or 'urine' mode. The measurement of sodium and potassium in blood, serum or plasma is made on an undiluted sample, whereas urine samples are automatically diluted before analysis with magnesium acetate solution. After the recommended daily calibration of the instrument, a sample can be analysed with the push of a single control button and results are displayed in approximately one minute.
Materials Reagents
All reagents required for sample analysis and calibration were supplied in a fluids pack by NOVA Biomedical. These consisted of a magnesium acetate diluent (52 mmol/1), potassium chloride reference solution ( Each of the lyophilised quality control materials was reconstituted according to the manufacturer's instructions. Materials used for between batch precision assessment were dispensed into small plastic tubes and stored at-15 C.
Methods Precision
Within-batch precision was assessed by replicate measurements of a selection of quality control materials (sera and urines) coveting a range of concentrations of sodium and potassium and also heparinised whole blood obtained from hospital patients. Up to 20 measurements were made on each specimen within as short a time as possible.i
Between-batch precision was assessed by replicate measurements of quality control materials (sera and urines) over a 20 day period. Each day an aliquot of each material was thawed, mixed and a single measurement made.
Linearity
The linearity of the instrument for sodium and potassium, in both the blood and urine modes, was assessed by measurement of a range of aqueous standards and diluted These were considered to be satisfactory.
The within-batch precision data of the NOVA for whole blood is shown in Table 2 . The average within-batch coefficient of variation for sodium was 0.3% (range 0.3 0.5) and for potassium 0.8% (range 0.4.-1.4). These levels of precision were also considered to be satisfactory.
The between-batch precision for whole blood could not be determined because of the unstable nature of the sample material.
The within-batch and between-batch precision figures for the NOVA in the urine mode using urine quality control materials are shown .in Table 3 . The average coefficients of variation for sodium were 1.2% (range 0.7 1.6) withinbatch and 2.1% (range 1.4 2.7) between-batch. The average within-batch coefficient of variation for potassium was 1.0% (range 1.0 1.1) and the average between-batch coefficient of variation was 2.7% (range 2.0 3.3). The authors consider the precision of the NOVA for sodium and potassium in the urine mode to be satisfactory. The greater coefficients of variation of the instrument in the urine mode as compared to the blood mode may be due to the additional urine dilution step.
Figures to 4 show the results of linearity experiments. In each figure a point represents the mean of three measurements made at the beginning, middle and end of the evaluation period. In the blood mode the NOVA gave linear results for sodium ( Figure 1 ) and potassium ( Figure 2 ) over the ranges investigated (50 170 mmol/1 and 8 mmol/1 respectively).
In the urine mode, linear results for sodium were obtained over the ranges 20 300 mmol/1 for aqueous standards and Figure 8 supports this recommendation. c) Quality control schemes Other ,investigations a) Probe. position
The NOVA sampling probe has two possible operating modes, a 'down' position for aspiration of samples from specimen cups, and an 'up' position for aspiration of samples from syringes or capillary tubes: The two sampling positions were compared by analysis of two quality control sera twenty times each in each sampling position. The differences in the mean sodium and potassium values for each sampling position were compared and the results, are shown in Table 9 .
The sodium values with the probe in the 'up' position were significantly higher than those in the 'down' position.
Specimen
showed a difference between the means of 0.7 mmol/1 (p<0.01) and specimen 2 a difference of 0.8 mmol/1 (p<0.01).
For potassium, significantly higher results were also obtained with the probe in the 'up' position. For specimen the difference between the the means ('up'-'down') was 0.02 mmol/1 (p<0.05) and for specimen 2 the difference was 0.03 mmol/1 (p<0.01). The authors are unable to explain why these differences should exist.
All of the analyses carried out during the evaluation period were performed with the probe in the 'up' position with the exception of the correlation studies performed on Groups and 2, described earlier.
b) Heparin
The NOVA Instruction Manual recommends that blood samples be collected with sodium heparin (10-20 units/ml) as anticoagulant, noting that sodium results will be elevated by approximately mmol/1. The majority of the measurements on heparinised plasma samples were carded out on specimens containing lithium heparin but some determinations were also made on samples containing other forms of heparin. An initial investigation on whole blood samples collected for blood gas analysis showed some anomalous results for NOVA sodium and potassium compared to the flame photometer results. The authors were interested in the effect of heparin in blood samples collected anaerobically for blood gas analysis and whether such samples were,suitable for determination of sodium and potassium by the NOVA 1.
Specimens for blood gas analysis are usually collected into syringes in which the dead space (needle + syringe end) is filled with a solution of sodium heparin. Since the dead space, the concentration of sodium heparin and the volume of blood collected may all vary, any effects on the measurement of sodium and potassium could also vary. Table 8 . Comparison of results obtained from whole blood with those from separated plasma from the same specimen, for sodium and potassium, using the NOVA 1 Group 4:15 specimens from hospital patients. These specimens were received for blood gas analysis and contained variable amounts of sodium heparin.
Group 5:21 specimens from apparently healthy laboratory staff.
These specimens were collected into standard 10 ml lithium heparin tubes. The effects of sodium heparin (5,000 units/ml heparin, 150 mmol/1 sodium; and 25,000 units/ml heparin, 750 mmol/1 sodium) and calcium heparin (25,000 units/ml) were investigated by adding 2 ml aliquots of a freshly collected whole blood specimen to a series of tubes containing varying amounts of these anticoagulants (from 20 #1 to 200 #1). Table 10 shows results obtained on plasma samples containing varying amounts and types of heparin.
The main effects are an increase in heparin concentration which produces a decrease in sodium and potassium values measured by NOVA 1, and increasing sodium concentration in the form of 25,000 units/ml s0dium heparin producing an increase in the sodium values measured by NOVA and flame photometry, although the increase in the NOVA values are less than those for flame photometry as a result of the heparin supressi0n effect.
The type and volume of heparin and the volume of blood collected should be carefully controlled, otherwise specimens of blood collected for blood gas analysis may not be suitable for the determination of sodium and potassium by the NOVA 1.
General comments
Instrument use In general, the NOVA is simple to operate and has some particularly useful features. The results determined on a specimen are displayed constantly until the next sample is aspirated, so that if necessary an operator can aspirate a specimen and IeaVe the instrument. The system of status codes is useful for identifying possible faults and in addition, results which may be unreliable (for example, due to the presence of air in the sample) are presented as a flashing display.
Instruction manual
The NOVA Instruction Manual is comprehensive and easy to follow. Included in the manual is a section on problem solving, which utilises a series of flow diagrams as an aid to the diagnosis and correction of each fault identified by a status code. This was found to be particularly useful.
Daily calibration
The Instruction Manual contains a section describing a series of checks and a calibration procedure to be followed each day These checks, were performed throughout the evaluation period and a record was maintained of the values recorded each day on four external standard solutions. These standards (two analysed in the blood mode and two in the urine mode) have limits ascribed to their values, within which results are considered to be'acceptable.
At the beginning of the evaluation period results on the external standards were well within these limits, but as the [2] has reported that increasing the sodium conc.entration from 19 to 171 mmol/1 had no effect on the potassium values, and that increasing the potassium concentration from 3.5 to 13.1 mmol/1 had no effect on the sodium /alues. He also reported that no interference was found from creatinine, uric For the analysis of whole blood, for almost 50% of the specimens analysed, the NOVA produced an error code indicating 'instability of sodium reading'. Repeat analysis of these specimens generally produced satisfactory results. This problem was not seen when separated plasma or serum samples were being analysed, nor when urine samples were being analysed in the urine mode. It was also noted that for some grossly lipaemic samples, no sodium or potassium results could be obtained on the NOVA as the instrument continually produced an error code which represented 'no air when required' in the flow path of the instrument.
Conclusions
The NOVA sodium and potassium analyser is simple and easy to operate. It has the advantage over flame photometry that gas and a compressed air supply are not required. When the instrument is left in the 'Star' mode it is immediately available for analytical determinations at the touch of a single 'Analyze' button. The precision of the instrument both within-and betweenbatch is satisfactory. There is, however, a significant difference between NOVA and flame photometer results for plasma sodium and potassium and the results confirm those reported by Ladenson [2] . The differences for potassium are small and possibly not clinically significant. The differences for sodium, however, are such that results obtained by NOVA are not directly comparable to those obtained by flame photometry. These differences cannot be explained simply on the basis of the lipid and protein content of plasma and it is recommended that new reference ranges should be established for plasma sodium determined by NOVA 1.
The diluents of certain commercial quality control materials contain substances which interfere with the performance of the NOVA electrodes. Heparin in high concentration can also affect the electrode performance and unless the heparin concentration in blood gas samples is carefully controlled then these samples may not be suitable for sodium and potassium determination by the NOVA 1.
